Lynn Stockwell
CEO and Exe. Chair of Board, Director, 10% Owner · Drugs Made In America Acquisition II Corp.
- 2025
- Sep 26, 2025
- 1
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Lynn Stockwell. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lynn Stockwell?
Lynn Stockwell is a corporate insider, tracked as CEO and Exe. Chair of Board, Director, 10% Owner of Drugs Made In America Acquisition II Corp. (DMII). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Lynn Stockwell last file a Form 4?
The only primary Form 4 on record is dated 26 September 2025.
Has Lynn Stockwell been buying or selling stock?
Recorded transactions: 2 open-market purchases and 1 open-market sale across all tracked filings.
